Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly RISPERDAL® CONSTA®, according to new data from a comparative study of both treatments in patients with schizophrenia. Results of the 13-week clinical trial were released this week.

10 Dec 2009

Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.

10 Dec 2009

Eli Lilly provides financial guidance for 2010

At its annual meeting today with the investment community, Eli Lilly and Company highlighted how its innovation-based strategy will enable it to better serve patients and compete effectively in a challenging health care environment. The company also detailed the progress being made in its labs and across its five new business units on an expanding pipeline of innovative molecules and marketed medicines, and provided investors with the company's financial guidance for 2010.

10 Dec 2009

NSBRI scientists to develop new techniques to help astronauts overcome balance disturbances

Upon returning to normal gravity, astronauts often suffer from balance problems that lead to dizziness and difficulty standing, walking and turning corners. Dr. Jacob Bloomberg is leading a group of National Space Biomedical Research Institute (NSBRI) scientists in a project to develop techniques to help astronauts adapt quickly to a new gravity environment and to overcome balance disturbances.

10 Dec 2009

Cell transplants may yield new therapies for dementia patients

Nerve cells transplanted into brain-damaged rats helped them to fully recover their ability to learn and remember, probably by promoting nurturing, protective growth factors, according to a new study.

10 Dec 2009

Researchers identify individualized treatments for pathological gambling

Pathological gambling can be successfully treated with medications that decrease urges and increase inhibitions, according to researchers at the annual meeting of the American College of Neuropsychopharmacology (ACNP).

10 Dec 2009

German researchers study target-oriented methods for children with brain tumor

Brain tumors are the primary cause of cancer mortality in children. Even if a cure is possible, young patients often suffer tremendously from the stressful treatment which can be harmful to the developing brain.

10 Dec 2009

Mouse study suggests response to injury-induced growth factors can be revived

Brain and spinal-cord injuries typically leave people with permanent impairment because the injured nerve fibers (axons) cannot regrow. A study from Children's Hospital Boston, published in the December 10 issue of the journal Neuron, shows that axons can regenerate vigorously in a mouse model when a gene that suppresses natural growth factors is deleted.

10 Dec 2009

Social scientists say compassion is humans' strongest trait

Researchers at UC Berkeley are challenging long-held beliefs that human beings are wired to be selfish. In a wide range of studies, social scientists are amassing a growing body of evidence to show we are evolving to become more compassionate and collaborative in our quest to survive and thrive.

10 Dec 2009

Behavioral intervention can improve cognitive performance in children

Carnegie Mellon University scientists Timothy Keller and Marcel Just have uncovered the first evidence that intensive instruction to improve reading skills in young children causes the brain to physically rewire itself, creating new white matter that improves communication within the brain.

10 Dec 2009

ACNP 2009 to feature research on PTSD, biomarkers for schizophrenia and treatment for gambling addiction

The 2009 American College of Neuropsychopharmacology Annual Meeting will feature innovative research on PTSD, biomarkers for schizophrenia and treatment for gambling addiction.

10 Dec 2009

Dermal stem cells may be useful for treating diabetic ulcers and neurological disorders

Scientists have discovered a new type of stem cell in the skin that acts surprisingly like certain stem cells found in embryos: both can generate fat, bone, cartilage, and even nerve cells.

10 Dec 2009

New protein discovery may serve as potential marker of drug addiction

Scientists are adding additional brush strokes to the revolutionary new image now emerging for star-shaped cells called astrocytes in the brain and spinal cord. Their report, which suggests a key role for astrocytes in morphine's ability to relieve pain and cause addiction, appears online in ACS' Journal of Proteome Research, a monthly publication.

10 Dec 2009

UC Davis receives NFL grant to study innovative ways for knee repair

NFL Charities, the charitable foundation of the National Football League, has awarded a grant of $125,000 to UC Davis for research on new ways to repair injured knees.

10 Dec 2009

Rise in U.S. disability health care spending, but preventive care may reduce expenditure

Just over one-quarter of U.S. adult health care spending was associated with disability in 2006, according to a new study by researchers at RTI International and the U.S. Centers for Disease Control & Prevention.

10 Dec 2009

JMC receives NIH grant to establish center of excellence for autoimmune diseases

The Department of Neurology at Jefferson Medical College (JMC) of Thomas Jefferson University has been awarded a multi-million dollar grant from the National Institutes of Health (NIH) for the creation of a center of excellence to study autoimmune diseases from basic science research to its translation into clinical applications.

10 Dec 2009

Additional data from ALS patients enrolled in confirmatory Phase III STAR trial announced

AVANIR Pharmaceuticals, Inc. today announced additional data from the subset of patients with amyotrophic lateral sclerosis (ALS) enrolled in the confirmatory Phase III STAR trial.

9 Dec 2009

NYSE Amex to delist Cortex Pharmaceuticals

Cortex Pharmaceuticals, Inc. announced that it has received notification from the NYSE Amex LLC indicating that, due to the Company’s non-compliance with certain continued listing standards as previously reported, the Exchange intends to delist the Company’s common stock from the NYSE Amex effective as of the close of business on Friday, December 11, 2009.

9 Dec 2009

Preliminary data from Phase 2 clinical trial of ZFP Therapeutic program presented

Sangamo BioSciences, Inc. announced today the presentation of preliminary data from the Phase 2 clinical trial of its ZFP Therapeutic(TM) program to develop SB-509 as a treatment for amyotrophic lateral sclerosis (ALS) at a Work in Progress session at the 20th International Symposium on ALS/MND held in Berlin, Germany.

9 Dec 2009

Rats exposed to passive smoking become dependent on nicotine, reveals study

Rats passively exposed to tobacco smoke become dependent on nicotine, according to a new study by Dr. Adrie Bruijnzeel and colleagues from the University of Florida in the US. Their findings of how rats' brains respond to exposure to tobacco smoke have implications for the study of the effects of tobacco smoke on the human brain even from passive exposure to other smokers, and for future studies testing new treatments for tobacco addiction. Their work has just been published online in Springer's journal Psychopharmacology.

9 Dec 2009

Brain News and Research

Further Reading

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Eli Lilly provides financial guidance for 2010

NSBRI scientists to develop new techniques to help astronauts overcome balance disturbances

Cell transplants may yield new therapies for dementia patients

Researchers identify individualized treatments for pathological gambling

German researchers study target-oriented methods for children with brain tumor

Mouse study suggests response to injury-induced growth factors can be revived

Social scientists say compassion is humans' strongest trait

Behavioral intervention can improve cognitive performance in children

ACNP 2009 to feature research on PTSD, biomarkers for schizophrenia and treatment for gambling addiction

Dermal stem cells may be useful for treating diabetic ulcers and neurological disorders

New protein discovery may serve as potential marker of drug addiction

UC Davis receives NFL grant to study innovative ways for knee repair

Rise in U.S. disability health care spending, but preventive care may reduce expenditure

JMC receives NIH grant to establish center of excellence for autoimmune diseases

Additional data from ALS patients enrolled in confirmatory Phase III STAR trial announced

NYSE Amex to delist Cortex Pharmaceuticals

Preliminary data from Phase 2 clinical trial of ZFP Therapeutic program presented

Rats exposed to passive smoking become dependent on nicotine, reveals study

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News